Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study of Tumor Infiltrating Lymphocytes in Cutaneous Squamous Cell Carcinoma and Merkel Cell Carcinoma

NCT07288073 is registered in ClinicalTrials.gov with Karam Khaddour, MD, MS as lead sponsor.

NCT NCT07288073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07288073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study of Tumor Infiltrating Lymphocytes in Cutaneous Squamous Cell Carcinoma and Merkel Cell Carcinoma
Lead sponsor
Karam Khaddour, MD, MS
Phase
Phase 2
Overall status
Recruiting
Start date
February 10, 2026
Completion date
June 29, 2029
Enrollment
14 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous squamous cell carcinoma, merkel cell carcinoma, metastatic cutaneous squamous cell carcinoma, skin cancer